| Description | Garenoxacin mesylate hydrate (Garenoxacin mesylate [USAN]) with potent antimicrobial activity, against common respiratory pathogens, including resistant strains. |
| Synonyms | Garenoxacin mesylate [USAN], 加雷沙星甲磺酸盐, BMS284756 (Mesylate hydrate) |
| molecular weight | 540.53 |
| Molecular formula | C23H20F2N2O4.CH4O3S.H2O |
| CAS | 223652-90-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 30 mg/mL (55.50 mM) |
| References | 1. Ince, D, Zhang, X, Silver, L. C,et al. Dual Targeting of DNA Gyrase and Topoisomerase IV: Target Interactions of Garenoxacin (BMS-284756, T-3811ME), a New Desfluoroquinolone[J]. Antimicrobial Agents & Chemotherapy, 46(11):3370-3380. 2. Waites K B , Crabb D M , Bing X , et al. In Vitro Susceptibilities to and Bactericidal Activities of Garenoxacin (BMS-284756) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas[J]. Antimicrobial Agents and Chemotherapy, 2003, 47(1):161-165. |